Michael Kavanaugh, M.D.

Dr. Kavanaugh was an attending staff physician at the San Francisco Veterans Administration Medical Center for more than 30 years and is an associate clinical professor of medicine at UCSF. Dr. Kavanaugh also serves on the Scientific Advisory Boards and Board of Directors of multiple companies. From 2015-2020, Dr. Kavanaugh was the senior vice president, chief scientific officer and head of non-clinical development at CytomX. Previously, he was senior vice president and chief scientific officer of Five Prime Therapeutics. Before Five Prime, Dr. Kavanaugh served as vice president of Novartis Vaccines & Diagnostics, Inc. and executive director of Oncology Biologics in the Novartis Institutes of Biomedical Research. He joined Novartis in 2006 as part of the company’s acquisition of the Chiron Corporation, where he was vice president and head of antibody and protein therapeutics research. Dr. Kavanaugh received his M.D. from Vanderbilt University and his B.A. in molecular biochemistry and biophysics from Yale University. He completed training in internal medicine, cardiovascular disease and molecular and cellular biology at the University of California, San Francisco, and the Cardiovascular Research Institute.